Application of the protection motivation theory to genetic testing for breast cancer risk

Preventive Medicine

Volumn 35, Issue 5, 2002, Pages 453-462

  Helmes, Almut W ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Breast cancer; Counseling; Genetic testing; Protection Motivation Theory; Risk perception

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CALCULATION; CANCER RISK; CONTROLLED STUDY; COUNSELING; DISEASE SEVERITY; FEMALE; GENETIC PROCEDURES; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MOTIVATION; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; THEORY; VALIDATION PROCESS;

EID: 0036433080     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.2002.1110     Document Type: Article

References (50)

1. Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 1996;25:527-36.
2. Andrykowski MA, Lightner R, Studts JL, Munn RK. Hereditary cancer risk notification and testing: How interested is the general population? J Clin Oncol 1997;15:2139-48.
3. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W. Attitudes and interest in genetic testing for breast and ovarian cancer. Susceptibility in diverse groups of women in Western Washington. Cancer Epidemiol Biomarkers Prev 1999;8:369-75.
4. Ulrich CM, Kristal AR, White E, Hunt JR, Durfy SJ, Potter JD. Genetic testing for cancer risk: A population survey on attitudes and intention. Community Genet 1998;1:213-22.
5. Helmes AW, Bowen DJ, Bowden R, Bengel J. Predictors of participation in genetic research in a primary care physician network. Cancer Epidemiol Biomarkers Prev 2000;9:1377-9.
6. Peshkin BN, DeMarco TA, Brogan BM, Lerman C, Isaacs C. BRCA1/2 testing: Complex themes in result interpretation. J Clin Oncol 2001;19:2555-65.
7. Collins FS. BRCA1 - Lots of mutations, lots of dilemmas. N Engl J Med 1996;334:186-8.
8. Eng C, Vijg J. Genetic testing: The problems and the promise. Nat Biotechnol 1997;15:422-6.
9. Bellg AJ, Matthews AK, Smith KC. False Reassurance from Genetic Testing for Breast Cancer Risk. San Francisco: Society of Behavioral Medicine, 1997.
10. Lerman C, Hughes C, Croyle R, Main D, Durham C, Snyder C, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 2000;31:75-80.
11. Rogers RW, Mewborn CR. Fear appeals and attitude change: Effects of a threat's noxiousness, probability of occurrence, and the efficacy of coping responses. J Personal Soc Psychol 1976;34:54-61.
12. Rogers RW. A protection motivation theory of fear appeals and attitude change. J Psychol 1975;91:93-114.
13. Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: A revised theory of protection motivation. In: Cacioppo JR, Petty RE, editors. Social Psychology: A Sourcebook. New York: Guilford, 1983:153-76.
14. Maddux JE. Protection motivation and self-efficacy: A revised theory of fear appeals and attitude change. J Exp Soc Psychol 1983;19:469-79.
15. Rogers RW, Prentice-Dunn S. Protection Motivation Theory. In: Gochman DS, editor. Handbook of Health Behavior Research I: Personal and Social Determinants. New York: Plenum, 1997:113-32.
16. Bengel J. Gesundheit, Risikowahrnehmung und Vorsorgeverhalten. Göttingen: Hogrefe, 1993.
17. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361-7.
18. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57:385-92.
19. Bowen DJ, Hickman K-M, Powers D. Importance of psychological variables in understanding risk perceptions and breast cancer screening of African American women. Women's Health Res Gender Behav Policy 1997;3:227-42.
20. Bosompra K, Flynn BS, Ashikaga T, Rairikar CJ, Worden JK, Solomon LJ. Likelihood of undergoing genetic testing for cancer risk: A population-based study. Prev Med 2000;30:155-66.
21. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 1993;22:284-92.
22. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-50.
23. Lerman C, Narod S, Lynch H. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65:414-20.
24. Baum A, Friedman AL, Zakowski SG. Stress and genetic testing for disease risk. Health Psychol 1997;16:8-19.
25. Jacobsen PB, Valdimarsdottir HB, Brown KL, Offit K. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 1997;59:459-66.
26. Bowen DJ, Helmes AW, Powers D, Andersen MR, Burke W, McTiernan A, et al. Predicting breast cancer screening intentions and behavior with emotion and cognition. J Soc Clin Psychol, in press.
27. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA. BRCA1 mutations and breast cancer in the general population. JAMA 1998;279:922-9.
28. Frank T, Manley S, Olopade O, Cummings S, Garber J, Bernhardt B, et al. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16:2417-25.
29. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 1995;273:577-85.
30. Bowen DJ, Christensen CL, Powers D, Graves DR, Anderson CAM. Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. J Clin Psychol Med Settings 1998;5:365-79.
31. Burke W, Culver J, Bowen D, Lowry D, Durfy S, McTiernan A, et al. Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genet 2000;90:361-8.
32. Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966;1:245-76.
33. Cattell RB, Vogelmann S. A comprehensive trial of the scree and KG criteria for determining the number of factors. Multivariate Behav Res 1977;12:289-325.
34. Diefenbach MA, Weinstein ND, O'Reilly J. Scales for assessing perceptions of health hazard susceptibility. Health Educ Res 1993;8:181-92.
35. Lerman C, Trock B, Rimer BK. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-67.
36. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979;41:209-18.
37. Hoyle RH. Structural Equation Modeling: Concepts, Issues, and Applications. Thousand Oaks (CA): Sage, 1995.
38. Jöreskog KG, Sorbom D. LISREL 8: Structural Equation Modeling with the SIMPLIS Command Language. Chicago: Scientific Software International, 1993.
39. Byrne BM. A Primer of LISREL. Basic Applications and Programming for Confirmatory Factor Analytic Models. New York: Springer-Verlag, 1989.
40. Hu L-T, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Eq Model 1999;6:1-55.
41. Backhaus K. Multivariate Analysemethoden: Eine Anwendungsorientierte Einführung, 9th Ed. Berlin: Springer-Verlag, 2000.
42. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Nat Cancer Inst 1992;84:24-30.
43. Erblich J, Bovbjerg DH, Valdimarsdottir HB. Looking forward and back: Distress among women at familial risk for breast cancer. Ann Behav Med 2000;22:53-9.
44. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-92.
45. Balint J, Shelton W. Regaining the initiative. Forging a new model of the patient-physician relationship. JAMA 1996;275:887-91.
46. Gallagher SM. Paternalism in healthcare decision making. Ostomy/Wound Manage 1998;44:22-5.
47. Guadagnoli E, Ward P. Patient participation in decision-making. Soc Sci Med 1998;47:329-39.
48. Fishbein M, Ajzen I. Predicting and understanding consumer behavior: Attitude-behavior correspondence. In: Ajzen I, Fishbein M, editors. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs: Prentice-Hall, 1980:148-72.
49. Geller G, Doksum T, Bernhardt BA, Metz S. Participation in breast cancer susceptibility testing protocols: Influence of recruitment source, altruism, and family involvement on women's decision. Cancer Epidemiol Biomarkers Prev 1999;8:377-83.
50. Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns 1987;10:117-38.